Target intelligence / Profile preview

Antigen-presenting cell phagosomal membrane

Molecular classification
Other, Cellular compartment
01

Overview

The antigen-presenting cell (APC) phagosomal membrane is a specialized lipid bilayer that forms during phagocytosis to sequester internalized pathogens or debris within a vesicle known as a phagosome [1]. In professional APCs like macrophages and dendritic cells, this membrane is essential for the immune response, as it serves as the site for pathogen degradation and the processing of antigens for presentation on MHC class I and II molecules [2]. The membrane is highly dynamic, undergoing a maturation process that involves sequential fusion with endosomes and lysosomes, which alters its protein and lipid composition to facilitate acidification and enzymatic activity [3]. While the membrane itself is a cellular compartment rather than a single protein, it contains numerous critical therapeutic targets, including Toll-like receptors (TLRs 3, 7, 8, and 9) and the NADPH oxidase complex (NOX2) [4]. Drugs such as chloroquine and hydroxychloroquine modulate the phagosomal environment by increasing pH, thereby interfering with antigen processing and TLR signaling, which is useful in treating autoimmune diseases like systemic lupus erythematosus [5]. Additionally, the phagosomal membrane is a focal point for vaccine delivery strategies aimed at enhancing cross-presentation to CD8+ T cells for cancer immunotherapy [6].

Other names
Phagosomal membranePhagolysosomal membraneEndophagosomal membranePhagosome membrane
02

Mechanism of action

Inhibition of phagosomal acidification, Toll-like receptor agonism, V-ATPase inhibition, NADPH oxidase modulation

03

Biological functions

Immune responseAntigen processingAntigen presentationPhagocytosisPathogen degradationAcidification
04

Disease associations

InfectionAutoimmune diseaseCancerInflammation
05

Safety considerations

Systemic immunosuppressionRetinopathy (long-term chloroquine use)Lysosomal storage dysfunctionOff-target membrane disruption
06

Interacting drugs

Chloroquine

4 more in the full profile.

07

Biomarkers

Phagosomal pHLAMP-1 expressionMHC class II surface expressionNOX2 activityRab7 expression

Beyond the preview

Go deeper on Antigen-presenting cell phagosomal membrane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Antigen-presenting cell phagosomal membrane.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call